You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 10, October 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Extract
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Laser Surgery
 •Refractive Surgery
 •Facial Plastic Surgery
 •Reconstructive Facial Surgery
 •Alert me on articles by topic

Laser In Situ Keratomileusis Flap Necrosis After Trigeminal Nerve Palsy

Germán A. Rocha, MD; Arantxa Acera, DSc; Juan A. Durán, MD

Arch Ophthalmol. 2007;125(10):1423-1425.

Laser in situ keratomileusis (LASIK) surgery can induce changes in the corneal epithelium owing to a neurotrophic phenomenon as a consequence of the sectioning of nerves during flap cutting.1 More profound alterations have been reported with a superior hinge, compared with a nasal hinge, and the associated effects tend to normalize over approximately 6 months,2 although it is possible that complete reinnervation and recovery of the basal state may not occur.3 Epithelial damage has also been associated with a reduced blinking rate, which favors corneal exposition.4

To date, various cases of post-LASIK neurotrophic epitheliopathy have been reported, characterized by symptoms and signs of dry eye and a spotted distribution of rose bengal dye. Recommended treatments include artificial tears, tear plug, and autologous serum,5 among others. Herein, we report a case of severe corneal flap necrosis that occurred after formation of a trigeminal nerve lesion of vascular origin. The patient was successfully treated with autologous plasma rich in growth factors (PRGF).6

Report of a Case

A male patient, 48 years old and a smoker, underwent LASIK surgery of both eyes in 2000 for myopia (–5.00 OD and –6.00 OS). A microkeratome (Hansatome; Bausch & Lomb, Rochester, New York) was used to produce a cut with a diameter of 8.5 mm and a depth of 160 µm. Postoperative evolution was without incident, and the patient demonstrated satisfactory visual and clinical recuperation.

In December 2003, the patient arrived at the accident and emergency service of a local general hospital with what appeared to be a left-sided cerebrovascular injury, which was confirmed on brain computed tomographic scan. The same scan revealed several areas of small lacunar infarctions, one of them affecting the deep area of the right medial cerebral artery, for which the patient was asymptomatic. He was hospitalized for 5 days.

In May 2004, as a result of visual loss in his left eye in the absence of pain, the patient consulted his ophthalmologist, who observed flap necrosis at the inferior edge (Figure 1). Lubricant treatment was initiated, and because of poor evolution, the patient was referred to our center for further treatment. At that stage, he had necrosis of the temporal half of the flap associated with anesthesia of the left trigeminal region. The patient was treated successively during the following weeks with artificial tears without preservatives, tear plug, autologous plasma, cyanoacrylate adhesive, amniotic membrane patch, and a bandage contact lens. Two months later, epithelialization was achieved, leaving as a consequence an anterior stromal opacity and notable topographic irregularity (Figure 2), which only permitted a best-corrected visual acuity of less than 20/200, as measured with eyeglasses.


Figure 1
View larger version (56K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Flap necrosis at the inferior edge of the laser in situ keratomileusis flap.



Figure 2
View larger version (152K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Orbscan (Bausch & Lomb, Rochester, New York) showing the corneal irregularity after partial flap necrosis.


To improve corneal irregularity, we proceeded in October 2005 to extirpate the flap remnant and apply temporal tarsorrhaphy together with 3 layers of amniotic membrane to increase the permanence period, together with temporal tarsorrhaphy. Despite this procedure, an extensive epithelial defect in the resected zone persisted 1 month later (Figure 3). Consequently, in December 2005 and with the informed consent of the patient, we decided to commence treatment with PRGF (GAC Medical, Vitoria, Spain). Initially, approximately 20 µL (1 drop) was administered every 2 hours, progressively reducing the frequency of administration in accord with the observed improvement. During the following 6 weeks, progressive epithelial closure was observed (Figure 4), although long-term irregularity of the epithelium and opacity of the underlying stroma persisted. The final best-corrected visual acuity was 20/200.


Figure 3
View larger version (84K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 3. Epithelial defect after the amniotic membrane dissolution (lissamine green).



Figure 4
View larger version (70K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 4. Improvement of the epithelial defect after treatment with autologous plasma rich in growth factors.



Comment

This case presents 2 particularly salient aspects. First, we report flap necrosis due to a trigeminal nerve lesion more than 3 years after LASIK surgery. Second, we describe a novel method for the successful treatment of neurotrophic ulcers.

The first aspect raises doubts about the capacity of a LASIK-operated on eye to respond to certain situations that involve aggression to the ocular surface. Without ruling out the possibility that the trigeminal lesion may have caused a corneal ulcer, this patient demonstrated flap necrosis with minimum repercussion in the deep corneal layers. On removal of the flap remains and despite measures to favor reepithelialization, signs of wound healing were not apparent. In light of this poor response and the risk of corneal melting, treatment with PRGF was initiated. This treatment has been used previously in maxillofacial and orthopedic surgery. Treatment with PRGF involves obtaining platelet and plasma proteins from the patient. The extract contains a high concentration of growth factors that can enhance the mechanisms of repair and regeneration in distinct tissues.6 It is prepared by centrifuging a sample of the patient's blood and obtaining a plasma fraction enriched in platelets from which growth factors are released with the addition of calcium chloride. This treatment is being used in other patients with different forms of neurotrophic keratitis and is being subjected to further evaluation to characterize its efficacy.


AUTHOR INFORMATION

Correspondence: Dr Durán, Instituto Clínico-Quirúrgico de Oftalmología, Virgen de Begoña 34, 48006 Bilbao, Spain (duran{at}icqo.org).

Financial Disclosure: None reported.


REFERENCES

1. Wilson SE, Ambrósio R. Laser in situ keratomileusis–induced neurotrophic epitheliopathy. Am J Ophthalmol. 2001;132(3):405-406. FULL TEXT | ISI | PUBMED
2. Donnenfeld ED, Solomon K, Perry HD; et al. The effect of hinge position on corneal sensation and dry eye after LASIK. Ophthalmology. 2003;110(5):1023-1029. FULL TEXT | ISI | PUBMED
3. Calvillo MP, McLaren JW, Hodge DO, Bourne WM. Corneal reinnervation after LASIK: prospective 3-year longitudinal study. Invest Ophthalmol Vis Sci. 2004;45(11):3991-3996. FREE FULL TEXT
4. Savini G, Barboni P, Zanini M, Tseng SCG. Ocular surface changes in laser in situ keratomileusis–induced neurotrophic epitheliopathy. J Refract Surg. 2004;20(6):803-809. [published correction appears in J Refract Surg. 2005;21(1):10]. ISI | PUBMED
5. Fuchsluger TA, Steuhl K, Meller D. Neurotrophic keratopathy: a post-LASIK case report [in German]. Klin Monatsbl Augenheilkd. 2005;222(11):901-904. FULL TEXT | PUBMED
6. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of protein for healing and tissue regeneration. Thromb Haemost. 2004;91(1):4-15. ISI | PUBMED

SECTION EDITOR: W. RICHARD GREEN, MD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.